Cheap and Commonplace: Making the Case for BCG and γδ T Cells in COVID-19

Cheap and Commonplace: Making the Case for BCG and γδ T Cells in COVID-19

Antigen-specific vaccines developed for the COVID-19 pandemic demonstrate a remarkable achievement and are currently being used in high income countries with much success. However, new SARS-CoV-2 variants are threatening this success via mutations that lessen the efficacy of antigen-specific antibod...

Full description

Bibliographic Details
Main Authors: Alexandra L. Morrison, Sally Sharpe, Andrew D. White, Mark Bodman-Smith
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Immunology
Subjects:
gamma delta T cell
Bacille Calmette-Guérin vaccine
trained immunity
non-specific immunity
COVID-19
innate immunity
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.743924/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.743924/full

Similar Items